The US Deprescribing Research Network

US Deprescribing Network

View the 2020 Annual Report 

 

Upcoming deadlines

Pilot and Grant Planning Awards - applications are now being accepted (deadline is January 22). Up to $60K per proposal for projects related to deprescribing research,  For more information, see https://deprescribingresearch.org/network-activities/grant-opportunities/

 

Junior Investigator Intensive - applications are now being accepted (deadline is February 1). This year-long virtual program is designed to advance the scholarship and career development of fellows, junior faculty, and other early-stage investigators interested in a research career that involves deprescribing research.  For more information, see https://deprescribingresearch.org/request-for-applicants-for-a-junior-investigator-intensive-program-in-deprescribing-research/

 

Pilot and Grant Planning Award RFAs released!

The US Deprescribing Research Network is pleased to announce 2 new RFAs! One-year pilot or grant planning awards, $60,000 direct costs, optional letter of intent due December 4. Visit our website and register for our webinar for more information!

View the RFA and timeline 

 

 

 

New USDeN Awardees!

The US Deprescribing Research Network has funded 2 grant planning and 4 pilot projects on a variety of topics related to deprescribing. Visit our website for detailed project descriptions!

Learn more about the projects

 

About the US Deprescribing Research Network

The goal of the US Deprescribing Research Network (USDeN) is to develop and disseminate evidence about deprescribing for older adults, and in doing so to help improve medication use among older adults and the outcomes that are important to them. Funded by the US National Institute on Aging, the network is a community of people united by a shared interest in improving research on deprescribing for older adults. The network’s key activities are designed to provide resources and supports that will catalyze expansion of the quality, quantity, and ultimate impact of deprescribing research, and to promote mutual learning and collaboration that is essential to this goal. 

 

Previous RFA Informational Webinar

 

 

 

Click to watch recording

 

Speakers

Amanda Mixon, MD
Co-Leader of USDeN Pilot & Exploratory Studies Core @Vanderbilt University
 
Sandra Simmons, PhD
Co-Leader of USDeN Pilot & Exploratory Studies Core @Vanderbilt University